Thank youImperial researchers are moving quickly to respond to the crisis, channelling their expertise to develop new vaccines and therapies, improve diagnostic tests, and strengthen epidemiology.

So far, 29 projects have been funded. These range from PPE for health care workers, investigating new treatments and developing new diagnostic devices. We are excited to share some of the projects supported by the COVID-19 Response Fund with you.


Ultrasensitive diagnostic device

Professor Molly Stevens and the Stevens Group are developing a point-of-care diagnostic device that detects ultra-low concentrations of the COVID-19 virus, enabling much earlier diagnosis than all currently reported serological PoC tests. In recent work to develop a more sensitive HIV test that would allow earlier diagnosis of the disease, the Stevens Group used ‘nanozymes’ (enzyme-mimicking catalytic nanoparticles) to enhance the sensitivity, up to 100 times, of an existing diagnostic method known in the field as lateral flow immunoassay. The resulting diagnostic device allows the presence of HIV to be detected even when at a very low levels, which makes earlier diagnosis possible. This technology will be repurposed for COVID-19 diagnosis, delivering potentially gamechanging ultrasensitive performance that gives a simple readout in 15 minutes.

Building PPE for NHS workers

Imperial volunteers are making more than 50,000 disposable visors for Imperial College Healthcare NHS Trust hospitals. An PPE
entire floor of Imperial’s 
Translation & Innovation Hub (I-HUB) in White City has been converted to assemble the visors, which will support Trust staff on the front lines of the coronavirus crisis.  More than 6,500 visors have already been delivered to Charing Cross Hospital. Tens of thousands more will be distributed across Trust hospitals over the coming weeks. The project is led by Imperial College Advanced Hackspace and the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial, in partnership with the Trust and their Infection Control team. Together, they developed, optimised and evaluated the visors to ensure they were appropriate for use. 

Low cost emergency ventilator

A team of bioengineers and medics have designed a low cost, high performance emergency ventilator to help patients with coronavirus. The ventilator, called JamVent, has been designed so that it doesn't rely on specialist parts, but can perform the demanding tasks necessary for treating patients with COVID-19. The device could offer a solution for the shortages worldwide, particularly for health services in developing countries. The design has been made freely available for manufacturers and health services around the world to download.